Condensed Consolidated Statements of Changes in Mezzanine Equity and Stockholder's Deficit - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock	Series B Convertible Preferred Stock	Redeemable Common Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		28,628	0	0
Beginning balance at Dec. 31, 2023		$ 7,855	$ 0	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of preferred stock (in shares)			9,250
Issuance of convertible preferred stock			$ 2,394
Preferred stock issuance costs			(102)
Accretion on convertible preferred stock		$ 1,212	$ 116
Conversion of preferred stock (in shares)		(1,178)
Conversion of preferred stock		$ (332)
Ending balance (in shares) at Mar. 31, 2024		27,450	9,250	0
Ending balance at Mar. 31, 2024		$ 8,735	$ 2,408	$ 0
Beginning balance (in shares) at Dec. 31, 2023					8,797,456
Beginning balance at Dec. 31, 2023	$ (37,531)				$ 1	$ 218,127	$ (255,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	(1,328)					(1,328)
Conversion of preferred stock (in shares)					171,719
Conversion of preferred stock	332					332
Issuance of common stock for restricted stock units vesting (in shares)					22,437
Issuance of common stock for employee stock purchase plans (in shares)					22,791
Issuance of common stock for employee stock purchase plan	92					92
Stock-based compensation	2,227					2,227
Net income (loss)	3,274						3,274
Ending balance (in shares) at Mar. 31, 2024					9,014,403
Ending balance at Mar. 31, 2024	(32,934)				$ 1	219,450	(252,385)
Beginning balance (in shares) at Dec. 31, 2023		28,628	0	0
Beginning balance at Dec. 31, 2023		$ 7,855	$ 0	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock				$ 4,308
Ending balance (in shares) at Sep. 30, 2024		11,479	9,250	750,000
Ending balance at Sep. 30, 2024		$ 4,652	$ 3,104	$ 4,313
Beginning balance (in shares) at Dec. 31, 2023					8,797,456
Beginning balance at Dec. 31, 2023	(37,531)				$ 1	218,127	(255,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(3,484)
Ending balance (in shares) at Sep. 30, 2024					15,393,881
Ending balance at Sep. 30, 2024	(21,459)				$ 2	237,682	(259,143)
Beginning balance (in shares) at Mar. 31, 2024		27,450	9,250	0
Beginning balance at Mar. 31, 2024		$ 8,735	$ 2,408	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on convertible preferred stock		$ 1,187	$ 348
Conversion of preferred stock (in shares)		(250)
Conversion of preferred stock		$ (83)
Ending balance (in shares) at Jun. 30, 2024		27,200	9,250	0
Ending balance at Jun. 30, 2024		$ 9,839	$ 2,756	$ 0
Beginning balance (in shares) at Mar. 31, 2024					9,014,403
Beginning balance at Mar. 31, 2024	(32,934)				$ 1	219,450	(252,385)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	(1,535)					(1,535)
Conversion of preferred stock (in shares)					36,443
Conversion of preferred stock	83					83
Issuance of common stock for restricted stock units vesting (in shares)					48,693
Stock-based compensation	2,104					2,104
Net income (loss)	(1,147)						(1,147)
Ending balance (in shares) at Jun. 30, 2024					9,099,539
Ending balance at Jun. 30, 2024	(33,429)				$ 1	220,102	(253,532)
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of redeemable common stock (in shares)				750,000
Issuance of convertible preferred stock				$ 4,308
Accretion on convertible preferred stock		$ 867	$ 348
Accretion on redeemable common stock				$ 5
Conversion of preferred stock (in shares)		(15,721)
Conversion of preferred stock		$ (6,054)
Ending balance (in shares) at Sep. 30, 2024		11,479	9,250	750,000
Ending balance at Sep. 30, 2024		$ 4,652	$ 3,104	$ 4,313
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	(1,215)					(1,215)
Accretion on redeemable common stock	(5)					(5)
Conversion of preferred stock (in shares)					2,291,686
Conversion of preferred stock	6,054					6,054
Issuance of common stock related to offering (in shares)					3,135,136
Common stock issuance costs	2,141					2,141
Issuance of warrants	382					382
RSU to RSA conversion (in shares)					387,309
Issuance of common stock for restricted stock units vesting (in shares)					439,659
Issuance of common stock for employee stock purchase plans (in shares)					36,534
Issuance of common stock for employee stock purchase plan	129					129
Exercises of options (in shares)					4,018
Exercise of options	17					17
Stock-based compensation	2,759					2,759
Net income (loss)	(5,611)						(5,611)
Issuance of common stock for employee stock purchase plan	11,601				$ 1	11,600
Ending balance (in shares) at Sep. 30, 2024					15,393,881
Ending balance at Sep. 30, 2024	(21,459)				$ 2	237,682	(259,143)
Beginning balance (in shares) at Dec. 31, 2024		11,479	9,250	750,000
Beginning balance at Dec. 31, 2024	12,937	$ 5,151	$ 3,452	$ 4,334
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on convertible preferred stock		$ 500	$ 348
Accretion on redeemable common stock				$ 21
Forfeiture of redeemable common stock (in shares)				(62,500)
Ending balance (in shares) at Mar. 31, 2025		11,479	9,250	687,500
Ending balance at Mar. 31, 2025		$ 5,651	$ 3,800	$ 4,355
Beginning balance (in shares) at Dec. 31, 2024					15,725,783
Beginning balance at Dec. 31, 2024	(29,751)				$ 2	238,442	(268,195)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	(848)					(848)
Accretion on redeemable common stock	(21)					(21)
Common stock issuance costs	7					7
Issuance of common stock for restricted stock units vesting (in shares)					56,149
Issuance of common stock for employee stock purchase plans (in shares)					26,917
Issuance of common stock for employee stock purchase plan	97					97
Stock-based compensation	1,684					1,684
Net income (loss)	3,025						3,025
Ending balance (in shares) at Mar. 31, 2025					15,808,849
Ending balance at Mar. 31, 2025	(25,807)				$ 2	239,361	(265,170)
Beginning balance (in shares) at Dec. 31, 2024		11,479	9,250	750,000
Beginning balance at Dec. 31, 2024	12,937	$ 5,151	$ 3,452	$ 4,334
Ending balance (in shares) at Sep. 30, 2025		11,479	9,250	687,500
Ending balance at Sep. 30, 2025	15,544	$ 6,651	$ 4,496	$ 4,397
Beginning balance (in shares) at Dec. 31, 2024					15,725,783
Beginning balance at Dec. 31, 2024	(29,751)				$ 2	238,442	(268,195)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(30,488)
Ending balance (in shares) at Sep. 30, 2025					16,502,152
Ending balance at Sep. 30, 2025	(54,143)				$ 2	244,538	(298,683)
Beginning balance (in shares) at Mar. 31, 2025		11,479	9,250	687,500
Beginning balance at Mar. 31, 2025		$ 5,651	$ 3,800	$ 4,355
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on convertible preferred stock		$ 500	$ 348
Accretion on redeemable common stock				$ 21
Ending balance (in shares) at Jun. 30, 2025		11,479	9,250	687,500
Ending balance at Jun. 30, 2025		$ 6,151	$ 4,148	$ 4,376
Beginning balance (in shares) at Mar. 31, 2025					15,808,849
Beginning balance at Mar. 31, 2025	(25,807)				$ 2	239,361	(265,170)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	(848)					(848)
Accretion on redeemable common stock	(21)					(21)
Conversion of preferred stock	3,579					3,579
Issuance of common stock for restricted stock units vesting (in shares)					58,928
Exercise of common stock warrants (in shares)					390,378
Stock-based compensation	1,588					1,588
Net income (loss)	(37,647)						(37,647)
Ending balance (in shares) at Jun. 30, 2025					16,258,155
Ending balance at Jun. 30, 2025	(59,156)				$ 2	243,659	(302,817)
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on convertible preferred stock		$ 500	$ 348
Accretion on redeemable common stock				$ 21
Ending balance (in shares) at Sep. 30, 2025		11,479	9,250	687,500
Ending balance at Sep. 30, 2025	15,544	$ 6,651	$ 4,496	$ 4,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on convertible preferred stock	(848)					(848)
Accretion on redeemable common stock	(21)					(21)
Issuance of common stock related to offering (in shares)					44,243
Issuance of common stock for restricted stock units vesting (in shares)					120,742
Exercise of common stock warrants (in shares)					11,840
Exercises of options (in shares)					67,172
Exercise of options	281					281
Stock-based compensation	1,306					1,306
Net income (loss)	4,134						4,134
Issuance of common stock for employee stock purchase plan	161				$ 0	161
Ending balance (in shares) at Sep. 30, 2025					16,502,152
Ending balance at Sep. 30, 2025	$ (54,143)				$ 2	$ 244,538	$ (298,683)